BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK

Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and m...

April 13, 2026 | Opinion | By Peter Grinbergs, Chief Medical Officer and Co‑founder of EQL

NCIS Leads Multidisciplinary Push To Transform Sarcoma Diagnosis And Care In Singapore

NCIS leads multi-institutional effort to develop expert multidisciplinary guidance to improve sarcoma diagnosis, referrals and outcomes Singapore is stren...

April 13, 2026 | News

TriNetX Acquires Zetta Genomics Assets To Strengthen Multiomic Data Capabilities

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...

April 09, 2026 | News

Syneron Bio Secures Series B Financing To Advance Macrocyclic Peptide Discovery Platform And Clinical Pipeline

Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on Marc...

April 06, 2026 | News

Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers

Aroa Biosurgery Limited announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the...

March 31, 2026 | News

AstraZeneca Reports Positive Phase 3 Results For Tozorakimab In COPD

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozoraki...

March 30, 2026 | News

Infosys To Acquire Optimum Healthcare IT To Strengthen AI Led Healthcare Transformation

Acquisition to unlock AI-powered cloud and digital transformation for healthcare providers Infosys a global leader in next-generation digital ...

March 27, 2026 | News

GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy

GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy...

March 23, 2026 | News

Everest Medicines Eyes Strategic Asia Expansion With Proposed Hasten Singapore Acquisition

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

March 19, 2026 | News

Samsung Bioepis And Sandoz Expand Global Biosimilar Alliance Across Five Assets

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and ...

March 18, 2026 | News

Unixell Biotech Secures US FDA IND Clearance For iPSC Derived Epilepsy Cell Therapy

Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational N...

March 16, 2026 | News

Eurofins Biomnis Develops LC MS MS Method For Detecting Cereulide Toxin In Human Stool Samples

Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announ...

March 12, 2026 | News

Vaxcellbio And Reber Genetics Form Strategic Partnership To Expand Companion Animal Immunotherapy Across Asia

Vaxcellbio (CEO Je-Jung Lee, MD, PhD), a leading immuno-oncology company, announced on Wednesday that it has signed a Master Partnership Agreement (MPA) wi...

March 12, 2026 | News

Nelipak Opens Asia Pacific Technical Development Center In Singapore To Accelerate Sterile Packaging Innovation

Nelipak Corporation (“Nelipak”), a leading global provider of healthcare packaging solutions,announced the opening of its new Asia-Pacific...

March 12, 2026 | News

Stay Connected